Interestingly, TP53 mutations are enriched in breast tumors from Black women relative to non-Black women relative to non-Black women (42, 66), a high-risk patient population with the lowest median age of pubertal onset, and where earlier puberty is associated with ER-negative breast cancer (41). This evidence concerns the gene TP53 and breast neoplasm.